We then enhanced the expression of miR-30a with mimics (Supplementary Fig S4G) and found that miR-30a OE in AML cells significantly decreased the abundances of EKL3 and IER2, well-characterized oncogenes, compared with those in negative control cells (Fig. 6E). The gene discussed is IER2; the disease is acute myeloid leukemia.